Doctor indicted on diet drug fraud charge
A doctor responsible for determining whether patients who had taken the once-popular diet drug fen-phen were eligible for compensation has been indicted on charges of fraud, the Justice Department announced Tuesday.
Fen-phen, a combination of fenfluarmine and phentermine, was taken off the market in 1997 after some of the millions of people who took it developed serious heart damage. Wyeth, the company that had marketed it, established a trust to pay benefits to the people who had been injured.
In the indictment, Dr. Abdur Razzak Tai, 77, is accused of participating in a scheme to submit fraudulent fen-phen claims.
- The Secret to Physician Engagement? It's Not Better Pay
- Two-Midnight Rule Must be Fixed or Replaced, Say Providers
- Don't Underestimate Emotional Intelligence
- 4 Reasons PCMH Principles Aren't Going Away
- Yale New Haven Health Partners with Tenet Healthcare in CT
- Care Coordination Tough to Define, Measure
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- Hospital Groups Strike Back at Hospital Rating Systems
- AHIP: Enormity of HIX Challenges Sinks In
- SCOTUS Review of NC Board Case 'A Very Big Deal' to Providers